In patients who do not respond to treatment, the value of continuous enteral feeding and especially of surgical re-intervention and pancreatic resection is uncertain (statements 5658 and 6062) and a conservative, non-surgical approach is recommended (statement 59)
Between-study heterogeneity was assessed using the Q statistic, (tau-squared), and I statistic

The range and variation in serum estradiol concentration in perimenopausal and postmenopausal women treated with transdermal estradiol in a real-world setting: a cross-sectional study Hypothalamic Estrogen Signaling and Adipose Tissue Metabolism in Energy Homeostasis A Novel Low-Impact Resistance Exercise Program Increases Strength and Balance in Females Irrespective of Menopause Status Weight loss response to semaglutide in postmenopausal women with and without hormone therapy use GLP-1 Medications May Lower Dementia Risk, Research Shows Glucagon-like peptide-1 suppresses neuroinflammation and improves neural structure Liraglutide restores impaired associative learning in individuals with obesity Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial Oral Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes Strength and muscle mass loss with aging process

Herpes simplex virus type 1 ICP27-dependent activation of NF-B
Moreover, TB001 treatment decreased the body weight and serum total cholesterol, LDL-cholesterol, and TNF- levels in transplant recipients, indicating metabolic improvements